Overview

Animal Growth Promoters and Performance Enhancers Market is estimated to value over USD 19.7 billion by 2027 end with a CAGR of over 5.5% during the forecast period 2020 to 2027.

The rising demand for meat across the world, the growing necessity for dealing with environmental factors and advancements in the research for antibiotics are the factors driving the growth of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Animal Growth Promoters and Performance Enhancers Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Animal Growth Promoters and Performance Enhancers Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Animal Growth Promoters and Performance Enhancers Market:

• Cargill Inc.
• Royal DSM N.V.
• Elanco Animal Health Inc.
• Merck & Co., Inc.
• Alltech Inc.
• Archer-Daniels-Midland Company (ADM)
• Vetoquinol
• Bupo Animal Health
• Chr. Hansen
• Novus International, Inc.
• Associated British Foods PLC
• Erber AG
• Phibro Animal Health Corporation
• Kemin Industries
• Nutreco (A Wholly Owned Subsidiary of SHV Group)

(Note: The list of the major players will be updated with the latest market scenario and trends)

Animal Growth Promoters and Performance Enhancers Market Segmentation:

By Product Type

• Antibiotic Growth Promoters
• Non-antibiotic Growth Promoters
• Acidifiers
• Prebiotics and Probiotics
• Feed Enzymes
• Phytogenics
• Hormones
• Other (amino acids and minerals)

By Animal Type

• Poultry
• Swine
• Livestock
• Aquaculture
• Other Animals (Equine, Rabbit, Camel, Deer, Yak, and Geese)

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Animal Growth Promoters and Performance Enhancers Market By Product Type, By Animal Type and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 
2.  Research Methodology 
       2.1 Research Data 
             2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
             2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  
3. Executive Summary
       3.1 Market Outlook
       3.2 Segment Outlook
       3.3 Competitive Insights
4. Global Animal Growth Promoters and Performance Enhancers Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Market Overview
       5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Animal Growth Promoters and Performance Enhancers Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Animal Growth Promoters and Performance Enhancers Market Analysis Tools
       6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
       6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
       6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
       6.4. Market Entry Strategies
       6.5. Case Studies
7. Global Animal Growth Promoters and Performance Enhancers Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
       7.1. Antibiotic Growth Promoters
       7.2. Non-antibiotic Growth Promoters
               7.2.1. Acidifiers
               7.2.2. Prebiotics and Probiotics
               7.2.3. Feed Enzymes
               7.2.4. Phytogenics
               7.2.5. Hormones
               7.2.6. Other (amino acids and minerals)
8. Global Animal Growth Promoters and Performance Enhancers Market, By Animal Type Historical Analysis and Forecast 2020-2027 (USD Million)
       8.1. Poultry
       8.2. Swine
       8.3. Livestock
       8.4. Aquaculture
       8.5. Other Animals (Equine, Rabbit, Camel, Deer, Yak, and Geese)
9.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       9.1. Introduction
       9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            9.2.1. U.S.A
            9.2.2. Canada
            9.2.3. Mexico
       9.3. Market Size (USD Million) Forecast for North America 2020-2027
10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       10.1. Introduction
       10.2. Regional Market Trends
       10.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.3.1. Brazil
            10.3.2. Venezuela
            10.3.3. Argentina
            10.3.4. Rest of Latin America
       10.4. Market Size (USD Million) Forecast for Latin America 2020-2027
11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       11.1. Introduction
       11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            11.2.1. Germany
            11.2.2. U.K
            11.2.3. France
            11.2.4. Italy
            11.2.5. Spain
            11.2.6. Russia
            11.2.7. Poland
            11.2.8. Switzerland
            11.2.9. Rest of Western Europe
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       12.1. Introduction
       12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
       12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             13.2.1. Saudi Arabia
             13.2.2. UAE
             13.2.3. South Africa
             13.2.4. Egypt
       13.3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
       14.1. Cargill Inc.                
                14.1.1. Company Overview
                14.1.2. Product Portfolio
                14.1.3. SWOT Analysis
                14.1.4. Financial Overview
                14.1.5. Strategic Overview
       14.2. Royal DSM N.V.
                14.2.1. Company Overview
                14.2.2. Product Portfolio
                14.2.3. SWOT Analysis
                14.2.4. Financial Overview
                14.2.5. Strategic Overview
       14.3. Elanco Animal Health Inc.
                14.3.1. Company Overview
                14.3.2. Product Portfolio
                14.3.3. SWOT Analysis
                14.3.4. Financial Overview
                14.3.5. Strategic Overview
       14.4. Merck & Co. Inc.
                14.4.1. Company Overview
                14.4.2. Product Portfolio
                14.4.3. SWOT Analysis
                14.4.4. Financial Overview
                14.4.5. Strategic Overview
       14.5. Alltech Inc.
                14.5.1. Company Overview
                14.5.2. Product Portfolio
                14.5.3. SWOT Analysis
                14.5.4. Financial Overview
                14.5.5. Strategic Overview
       14.6. Archer-Daniels-Midland Company (ADM)
                14.6.1. Company Overview
                14.6.2. Product Portfolio
                14.6.3. SWOT Analysis
                14.6.4. Financial Overview
                14.6.5. Strategic Overview
       14.7. Vetoquinol
                14.7.1. Company Overview
                14.7.2. Product Portfolio
                14.7.3. SWOT Analysis
                14.7.4. Financial Overview
                14.7.5. Strategic Overview
       14.8. Bupo Animal Health
                14.8.1. Company Overview
                14.8.2. Product Portfolio
                14.8.3. SWOT Analysis
                14.8.4. Financial Overview
                14.8.5. Strategic Overview
       14.9. Chr. Hansen
                14.9.1. Company Overview
                14.9.2. Product Portfolio
                14.9.3. SWOT Analysis
                14.9.4. Financial Overview
                14.9.5. Strategic Overview
       14.10. Novus International, Inc.
                14.10.1. Company Overview
                14.10.2. Product Portfolio
                14.10.3. SWOT Analysis
                14.10.4. Financial Overview
                14.10.5. Strategic Overview
       14.11. Associated British Foods PLC
                14.11.1. Company Overview
                14.11.2. Product Portfolio
                14.11.3. SWOT Analysis
                14.11.4. Financial Overview
                14.11.5. Strategic Overview
       14.12. Erber AG
                14.12.1. Company Overview
                14.12.2. Product Portfolio
                14.12.3. SWOT Analysis
                14.12.4. Financial Overview
                14.12.5. Strategic Overview
       14.13. Phibro Animal Health Corporation
                14.13.1. Company Overview
                14.13.2. Product Portfolio
                14.13.3. SWOT Analysis
                14.13.4. Financial Overview
                14.13.5. Strategic Overview
       14.14. Kemin Industries
                14.14.1. Company Overview
                14.14.2. Product Portfolio
                14.14.3. SWOT Analysis
                14.14.4. Financial Overview
                14.14.5. Strategic Overview
       14.15. Nutreco (A Wholly Owned Subsidiary of SHV Group)
                14.15.1. Company Overview
                14.15.2. Product Portfolio
                14.15.3. SWOT Analysis
                14.15.4. Financial Overview
                14.15.5. Strategic Overview
15. FutureWise SME key takeaway points for Client

Tables

Figures